Tianyu Pharmaceutical
Tianyu Pharmaceutical Co., Ltd., commonly referred to as Tianyu Pharma, is a prominent player in the pharmaceutical industry, headquartered in China (CN). Established in the early 2000s, the company has made significant strides in the development and manufacturing of high-quality pharmaceutical products, particularly in the fields of oncology and cardiovascular health. With a strong operational presence across various regions in Asia and beyond, Tianyu Pharma is dedicated to innovation and excellence. The company’s core offerings include a diverse range of generic and proprietary medications, distinguished by their efficacy and safety profiles. Notably, Tianyu has achieved recognition for its commitment to research and development, positioning itself as a trusted name in the global pharmaceutical market.
DitchCarbon Score
How does Tianyu Pharmaceutical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tianyu Pharmaceutical's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tianyu Pharmaceutical's reported carbon emissions
Tianyu Pharmaceutical, headquartered in China, currently does not report specific carbon emissions data. However, the company has made significant commitments towards climate action. As of June 19, 2025, Zhejiang Tianyu Pharmaceutical Co., Ltd. is committed to near-term climate targets, although specific reduction targets have not been disclosed. The company is actively engaged in sustainability initiatives within the chemicals sector, reflecting a growing trend among corporations to address climate change. While no absolute emissions figures are available, Tianyu Pharmaceutical's commitment to near-term targets indicates a proactive approach to reducing its carbon footprint. As part of its climate strategy, Tianyu Pharmaceutical is aligned with the Science Based Targets initiative (SBTi), showcasing its dedication to setting science-based emissions reduction targets. This commitment is crucial for the company as it navigates the challenges of climate change and aims to contribute positively to global sustainability efforts.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tianyu Pharmaceutical is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
